Can We Predict Daily Adherence to Warfarin?: Results From the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study

BACKGROUND: Warfarin is the primary therapy to prevent stroke and venous thromboembolism. Significant periods of nonadherence frequently go unreported by patients and undetected by providers. Currently, no comprehensive screening tool exists to help providers assess the risk of nonadherence at the t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Platt, Alec B., Localio, A. Russell, Brensinger, Colleen M., Cruess, Dean G., Christie, Jason D., Gross, Robert, Parker, Catherine S., Price, Maureen, Metlay, Joshua P., Cohen, Abigail, Newcomb, Craig W., Strom, Brian L., Laskin, Mitchell S., Kimmel, Stephen E.
Formato: Artigo
Idioma:Inglês
Publicado em: American College of Chest Physicians 2010
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2851552/
https://ncbi.nlm.nih.gov/pubmed/19903973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.09-0039
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados